Identification of an alternative transcript of ABCA1 gene in different human cell types

Biochemical and Biophysical Research Communications

Volumn 283, Issue 3, 2001, Pages 590-597

  Bellincampi, Lorenza ^a,b   Simone, Maria Luisa ^b   Motti, Corradino ^c   Cortese, Claudio ^a   Bernardini, Sergio ^a   Bertolini, Stefano ^d   Calandra, Sebastiano ^b  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^c UNIVERSITY OF TERAMO   (Italy)

^d UNIVERSITY OF GENOA   (Italy)

Author keywords

ABCA1 gene; Alternative splicing; Exon skipping; Posttranscriptional regulation

Indexed keywords

ABC TRANSPORTER; ABC TRANSPORTER A1; CARRIER PROTEIN; UNCLASSIFIED DRUG;

ALTERNATIVE RNA SPLICING; ARTICLE; CELL STRAIN HEPG2; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ANALYSIS; GENE AMPLIFICATION; GENE CASSETTE; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LEUKEMIA CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN FIBROBLAST; SMOOTH MUSCLE FIBER; T LYMPHOCYTE;

EID: 0034816236     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.2001.4823     Document Type: Article

References (33)

1. The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease
2. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency
3. Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1
4. Mutations in the ABC1 gene in familial HDL deficiency with defective cholesterol efflux
5. An inventory of the human ABC proteins
6. Defective removal of cellular cholesterol and phospholipids by apolipoprotein A-I in Tangier disease
7. The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway
8. Cellular cholesterol transport and effiux in fibroblasts are abnormal in subjects with familial HDL deficiency
9. Familial high density lipoprotein deficiency: Tangier disease
10. Complete genomic sequence of the human ABCA1 gene: Analysis of the human and mouse ATP-binding cassette A promoter
11. Analysis of hABC1 gene 5′ end: Additional peptide sequence, promoter region, and four polymorphisms
12. Molecular cloning of the human ATP-binding cassette transporter 1 (hABC1): Evidence for sterol-dependent regulation in macrophages
13. Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor/retinoid X receptor
14. ABC1 gene expression and apo A-I-mediated cholesterol efflux are regulated by LXR
15. Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers
16. A point mutation in ABC1 gene in a patient with severe premature heart disease and mild clinical phenotype of Tangier disease
17. Transcription termination, RNA processing and postranscriptional control
18. DNA structure and gene expression
19. Mutually exclusive splicing of α-tropomyosin exons enforced by an unusually lariat branch point location: Implications for constitutive splicing
20. Branch point selection in alternative splicing of tropomyosin pre-mRNAs
21. The stepwise assembly of a pre-mRNA splicing complex requires U-snRNPs and specific intron sequences
22. A role for exon sequences and splice-site proximity in splice-site selection
23. Role of the 3′ splice site consensus sequences in mammalian pre-mRNA splicing
24. A factor, U2AF, is required for U2 snRNP biding and splicing complex assembly
25. Developmentally induced, muscle-specific trans factors control the differential splicing of alternative and constitutive troponin T exons
26. The rat α-tropomyosin gene generates a minimum of six different mRNAs coding for striated, smooth and non-muscle isoforms by alternative splicing
27. Extensive post-transcriptional deletion of the coding sequences for part of nucleotide-binding fold 1 in respiratory epithelial mRNA transcripts of the cystic fibrosis transmembrane conductance regulator gene is not associated with the clinical manifestations of cystic fibrosis
28. Genetic basis of variable exon 9 skipping in cystic fibrosis transmembrane conductance regulator mRNA
29. Polyvariant mutant cystic fibrosis transmembrane conductance regulator genes
30. Increased proportion of exon 9 alternatively spliced CFTR transcripts in vas deferens compared with nasal epithelial cells
31. Variable deletion of exon 9 coding sequence in cystic fibrosis transmembrane conductance regulator gene mRNA transcripts in normal bronchial epithelium
32. Higher proportion of intact exon 9 CFTR mRNA in nasal epithelium compared with vas deferens
33. Cystic fibrosis transmembrane conductance regulator splice variants are not conserved and fail to produce chloride channels